SURGITRON

K980170 · Ellman Intl., Inc. · GEI · Jun 29, 1998 · General, Plastic Surgery

Device Facts

• Record ID: K980170
• Device Name: SURGITRON
• Applicant: Ellman Intl., Inc.
• Product Code: GEI · General, Plastic Surgery
• Decision Date: Jun 29, 1998
• Decision: SESE
• Submission Type: Traditional
• Regulation: 21 CFR 878.4400
• Device Class: Class 2
• Attributes: Therapeutic

Intended Use

Cutting Skin Incisions, Biopsy, Cysts, Abscesses, Tumors, Cosmetic Repairs, Development of Skin Flaps, SkinTags, Nevi, Keratosis, Oculoplastic Procedures, Blepharoplasty, Aponeurotic Repair, Levator Resection, Arthroscopic Procedures. Blended Cutting and Coagulation Skin Tags, Papilloma Keloids, Keratosis, Verrucae, Basal CellCarcinoma, Nevi, Fistulas, Epithelioma, Cosmetic Repairs, Cysts, Abscesses, Development of Skin Flaps, Oculoplastic Procedures, Arthroscopic Procedures. Hemostasis Control of Bleeding, Epilation, Telangiectasia Fulguration Basal Cell Carcinoma, Papilloma, Cyst Destruction, Tumors, Verrucae, Hemostasis. Bipolar Pinpoint, Precise Coagulation, Pinpoint Hemostasis in any field (Wet or Dry).

Device Story

Surgitron is an electrosurgical device used for cutting, coagulation, hemostasis, and fulguration of soft tissue. It operates by delivering high-frequency electrical energy to tissue via specialized electrodes. The device is intended for use by clinicians in surgical settings for various procedures, including dermatology, oculoplastics, and arthroscopy. By providing precise tissue interaction, it enables surgeons to perform incisions, manage bleeding, and remove lesions or tumors. The output is controlled by the surgeon to achieve specific clinical effects—cutting, blended cutting/coagulation, or pinpoint bipolar coagulation—thereby facilitating surgical access and tissue management while minimizing collateral damage.

Clinical Evidence

No clinical data provided; substantial equivalence is based on the device's status as a pre-amendment device.

Technological Characteristics

Electrosurgical generator utilizing high-frequency electrical energy for tissue cutting and coagulation. Supports monopolar and bipolar modes. Form factor is a clinical-grade surgical console. No software or digital processing described.

Indications for Use

Indicated for surgical procedures requiring cutting, coagulation, hemostasis, and fulguration of soft tissue, including skin incisions, biopsies, tumor removal, cosmetic repairs, oculoplastic procedures, and arthroscopic procedures.

Regulatory Classification

Identification

An electrosurgical cutting and coagulation device and accessories is a device intended to remove tissue and control bleeding by use of high-frequency electrical current.

Submission Summary (Full Text)

{0}------------------------------------------------

Image /page/0/Picture/1 description: The image shows the logo for the Department of Health & Human Services USA. The logo is circular, with the text "DEPARTMENT OF HEALTH & HUMAN SERVICES USA" arranged around the perimeter. Inside the circle is an abstract symbol that resembles a stylized human figure or a bird in flight.

Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850

JUN 2 9 1998

Frank Lin ·Director of R&D Engineering Ellman International, Inc. 1135 Railroad Avenue Hewlett, New York 11557-2316

Re: K980170 Trade Name: Surgitron Regulatory Class: II Product Code: GEI Dated: April 21, 1998 Received: April 24, 1998

Dear Mr. Lin:

We have reviewed your Section 510(k) notification of intent to market the device referenced above and we have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.

If your device is classified (see above) into either class II (Special Controls) or class III (Premarket Approval), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 895. A substantially equivalent determination assumes compliance with the current Good Manufacturing Practice requirement, as set forth in the Quality System Regulation (QS) for Medical Devices: General regulation (21 CFR Part 820) and that, through periodic (OS) inspections, the Food and Drug Administration (FDA) will verify such assumptions. Failure to comply with the GMP regulation may result in regulatory action. In addition, FDA may publish further announcements concerning your device in the Federal Register. Please note: this response to your premarket notification submission does not affect any obligation you might have under sections 531 through 542 of the Act for devices under the Electronic Product Radiation Control provisions, or other Federal laws or regulations.

{1}------------------------------------------------

Page 2 - Mr. Lin

This letter will allow you to begin marketing your device as described in your 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market.

If you desire specific advice for your device on our labeling regulation (21 CFR Part 801 and additionally 809.10 for in vitro diagnostic devices), please contact the Office of Compliance at [phone]. Additionally, for questions on the promotion and advertising of your device, please contact the Office of Compliance at [phone]. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR 807.97). Other general information on your responsibilities under the Act may be obtained from the Division of Small Manufacturers Assistance at its toll-free number [phone] or [phone] or at its internet address "http://www.fda.gov/cdrh/dsmamain.html".

Sincerely yours,

Celia M. Witten, Ph.D., M.D.

Celia M. Witten, Ph.D., M.D. Director Division of General and Restorative Devices Office of Device Evaluation Center for Devices and Radiological Health

Enclosure

{2}------------------------------------------------

510K Notification K980170 Surgitron - Orthopedics Use page 5

ellman international

510(k) Number (if known): K980170

Device Name:

Indication For Use: is idendical to the Surgitron as a preammendment device such as:

* Cutting Skin Incisions, Biopsy, Cysts, Abscesses, Tumors, Cosmetic Repairs, Development of Skin Flaps, SkinTags, Nevi, Keratosis, Oculoplastic Procedures, Blepharoplasty, Aponeurotic Repair, Levator Resection, Arthroscopic Procedures.

* Blended Cutting and Coagulation Skin Tags, Papilloma Keloids, Keratosis, Verrucae, Basal CellCarcinoma, Nevi, Fistulas, Epithelioma, Cosmetic Repairs, Cysts, Abscesses, Development of Skin Flaps, Oculoplastic Procedures, Arthroscopic Procedures.

- * Hemostasis Control of Bleeding, Epilation, Telangiectasia
- * Fulguration Basal Cell Carcinoma, Papilloma, Cyst Destruction, Tumors, Verrucae, Hemostasis.
- * Bipolar Pinpoint, Precise Coagulation, Pinpoint Hemostasis in any field (Wet or Dry).

(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED)

| | Concurrence of CDRH, Office of Device Evaluation (ODE) | | |
|-----------------------------------------|--------------------------------------------------------|----|--------------------------|
| (Division Sign-Off) | | | |
| Division of General Restorative Devices | | | |
| 510(k) Number | K980170 | | |
| Prescription Use | X | OR | Over-The- Counter Use |
| (Per 21 CFR 801.109) | | | (Optional Format 1-2-96) |